drugset / Trial / NCT00538902
Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate
RandomizedParallel-groupTriple-blindTreatment
Summary
A study to assess the safety and efficacy of adalimumab administered as a subcutaneous injection in adult Chinese subjects with rheumatoid arthritis and treated with methotrexate
Timeline
- Start
- 2007-08
- Primary completion
- 2008-07
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adalimumab | Monoclonal antibody | 40 mg | Subcutaneous |
| Subject | Adalimumab | Monoclonal antibody | 80 mg | Subcutaneous |